Ya Cao Selected Research

Ya Cao Research Topics

Disease

167	Neoplasms (Cancer) 04/2024 - 01/2002
73	Nasopharyngeal Carcinoma 10/2023 - 01/2000
33	Carcinogenesis 11/2021 - 01/2002
31	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2002
27	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 09/2015
14	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2011
11	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2007
9	Infections 01/2022 - 07/2008
9	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
6	Liver Neoplasms (Liver Cancer) 08/2019 - 10/2015
5	Cholangiocarcinoma 03/2021 - 12/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 05/2017
3	Disease Progression 04/2024 - 10/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
3	Circulating Neoplastic Cells 12/2021 - 01/2018
3	Latent Infection 09/2021 - 06/2007
3	Lymphatic Metastasis 11/2019 - 07/2005
2	Hypoxia (Hypoxemia) 02/2024 - 12/2018
2	Osteosarcoma (Osteogenic Sarcoma) 11/2023 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 03/2021
2	Triple Negative Breast Neoplasms 01/2022 - 03/2021
2	Dehydration (Water Stress) 04/2021 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 06/2020 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 03/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2000
37	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023 - 05/2002
20	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2011
19	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2002
13	MicroRNAs (MicroRNA)IBA 02/2023 - 11/2011
13	Catalytic DNA (Deoxyribozyme)IBA 01/2022 - 07/2005
11	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 11/2004
9	RNA (Ribonucleic Acid)IBA 02/2023 - 11/2009
9	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
8	EnzymesIBA 02/2023 - 06/2014
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2002
8	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 06/2003
8	NF-kappa B (NF-kB)IBA 01/2021 - 01/2002
8	ChromatinIBA 01/2020 - 04/2013
8	grifolinIBA 01/2018 - 06/2005
8	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2010 - 01/2002
7	Adenosine Triphosphate (ATP)IBA 07/2022 - 06/2014
6	Long Noncoding RNAIBA 11/2023 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 08/2014
6	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017 - 09/2005
6	Phosphotransferases (Kinase)IBA 12/2015 - 10/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 01/2018
5	LipidsIBA 03/2020 - 11/2017
5	CytokinesIBA 06/2019 - 01/2016
5	Protein Kinases (Protein Kinase)IBA 01/2018 - 02/2009
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2023 - 10/2015
4	ErbB Receptors (EGF Receptor)IBA 03/2021 - 05/2002
4	Chemokine ReceptorsIBA 01/2021 - 07/2005
4	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2012
3	Fetal Proteins (Fetoprotein)IBA 10/2023 - 10/2020
3	lenvatinibIBA 01/2023 - 10/2022
3	LigandsIBA 01/2023 - 07/2005
3	Tumor Biomarkers (Tumor Markers)IBA 08/2022 - 01/2010
3	Estrogen ReceptorsIBA 01/2022 - 05/2013
3	Proline (L-Proline)FDA Link 01/2022 - 01/2020
3	Nucleic AcidsIBA 12/2021 - 01/2019
3	SesquiterpenesIBA 01/2021 - 08/2015
3	trichothecinIBA 01/2021 - 07/2019
3	Competitive Endogenous RNAIBA 04/2020 - 11/2019
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 01/2017
3	TransferasesIBA 06/2019 - 01/2002
3	Interleukin-8 (Interleukin 8)IBA 06/2019 - 05/2012
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2008
3	Mitogen-Activated Protein Kinase 3IBA 01/2019 - 03/2013
3	Epstein-Barr virus EBV-associated membrane antigenIBA 01/2018 - 06/2003
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2018 - 07/2004
3	neoalbaconolIBA 01/2017 - 02/2015
3	Death-Associated Protein KinasesIBA 08/2015 - 01/2011
3	StathminIBA 02/2014 - 03/2009
3	ezrinIBA 10/2011 - 01/2007
2	InterferonsIBA 12/2023 - 01/2019
2	Metal-Organic FrameworksIBA 12/2023 - 10/2020
2	Peptides (Polypeptides)IBA 10/2023 - 01/2019
2	Carcinoembryonic AntigenIBA 10/2023 - 12/2017
2	CarbohydratesIBA 10/2023 - 12/2017
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	NADP (NADPH)IBA 10/2022 - 01/2022
2	Fumarate Hydratase (Fumarase)IBA 04/2022 - 10/2016
2	Amino Acids FDA Link 01/2022 - 03/2015
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 11/2017
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 10/2010
2	Arginine (L-Arginine)FDA Link 01/2022 - 01/2013
2	Viral ProteinsIBA 12/2021 - 06/2012
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2017
2	CarcinogensIBA 12/2021 - 10/2011
2	MethyltransferasesIBA 11/2021 - 01/2017
2	CateninsIBA 01/2021 - 01/2016
2	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 09/2015
2	PolyphenolsIBA 03/2020 - 03/2013
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020 - 01/2018

Therapy/Procedure

38	Therapeutics 04/2024 - 03/2004
13	Radiotherapy 01/2024 - 06/2011
5	Immunotherapy 01/2023 - 01/2020
5	Hepatectomy 01/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
3	Liver Transplantation 10/2022 - 01/2021